US Patent Issued to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION on June 9 for "Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides" (Florida Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,770, issued on June 9, was assigned to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION Inc. (Gainesville, Fla.).

"Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides" was invented by Qiuhong Li (Gainesville, Fla.) and Mohan Raizada (Gainesville, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are polynucleic acids and expression vectors for the expression and secretion of angiotensin peptide fragments (e.g., angiotensin-(1-7)) in probiotic bacteria. Provided herein are also probiotic compositions that enable efficient, cost-effective and patient friendly oral therapeutics for ...